Cancer biology. A matter of dosage. [Science. 2002] - PubMed

loading

BLM heterozygosity and the risk of colorectal cancer. [Science. 2002]
BLM heterozygosity and the risk of colorectal cancer.
Gruber SB, Ellis NA, Scott KK, Almog R, Kolachana P, Bonner JD, Kirchhoff T, Tomsho LP, Nafa K, Pierce H, et al. Science. 2002 Sep 20; 297(5589):2013.
Review Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. [Expert Rev Mol Diagn. 2004]
Review Clinical features of Bloom syndrome and function of the causative gene, BLM helicase.
Kaneko H, Kondo N. Expert Rev Mol Diagn. 2004 May; 4(3):393-401.
Enhanced tumor formation in mice heterozygous for Blm mutation. [Science. 2002]
Enhanced tumor formation in mice heterozygous for Blm mutation.
Goss KH, Risinger MA, Kordich JJ, Sanz MM, Straughen JE, Slovek LE, Capobianco AJ, German J, Boivin GP, Groden J. Science. 2002 Sep 20; 297(5589):2051-3.
Review DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. [Hum Mol Genet. 2001]
Review DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders.
Mohaghegh P, Hickson ID. Hum Mol Genet. 2001 Apr; 10(7):741-6.
BLM is an early responder to DNA double-strand breaks. [Biochem Biophys Res Commun. 2006]
BLM is an early responder to DNA double-strand breaks.
Karmakar P, Seki M, Kanamori M, Hashiguchi K, Ohtsuki M, Murata E, Inoue E, Tada S, Lan L, Yasui A, et al. Biochem Biophys Res Commun. 2006 Sep 15; 348(1):62-9. Epub 2006 Jul 17.

Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network. [PLoS Genet. 2012]
Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network.
Pylkäs K, Vuorela M, Otsukka M, Kallioniemi A, Jukkola-Vuorinen A, Winqvist R. PLoS Genet. 2012; 8(6):e1002734. Epub 2012 Jun 21.
Review A continuum model for tumour suppression. [Nature. 2011]
Review A continuum model for tumour suppression.
Berger AH, Knudson AG, Pandolfi PP. Nature. 2011 Aug 10; 476(7359):163-9. Epub 2011 Aug 10.
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. [Cell Death Differ. 2011]
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, et al. Cell Death Differ. 2011 Jul; 18(7):1174-83. Epub 2011 Jan 21.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Cancer biology. A matter of dosage.
Cancer biology. A matter of dosage.
Science. 2002 Oct 25 ;298(5594):761-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed